216 related articles for article (PubMed ID: 26012550)
1. Human Schlafen 5 (SLFN5) Is a Regulator of Motility and Invasiveness of Renal Cell Carcinoma Cells.
Sassano A; Mavrommatis E; Arslan AD; Kroczynska B; Beauchamp EM; Khuon S; Chew TL; Green KJ; Munshi HG; Verma AK; Platanias LC
Mol Cell Biol; 2015 Aug; 35(15):2684-98. PubMed ID: 26012550
[TBL] [Abstract][Full Text] [Related]
2. Expression and regulatory effects of murine Schlafen (Slfn) genes in malignant melanoma and renal cell carcinoma.
Mavrommatis E; Arslan AD; Sassano A; Hua Y; Kroczynska B; Platanias LC
J Biol Chem; 2013 Nov; 288(46):33006-15. PubMed ID: 24089532
[TBL] [Abstract][Full Text] [Related]
3. Role of interferon {alpha} (IFN{alpha})-inducible Schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells.
Katsoulidis E; Mavrommatis E; Woodard J; Shields MA; Sassano A; Carayol N; Sawicki KT; Munshi HG; Platanias LC
J Biol Chem; 2010 Dec; 285(51):40333-41. PubMed ID: 20956525
[TBL] [Abstract][Full Text] [Related]
4. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
[TBL] [Abstract][Full Text] [Related]
5. SLFN5 suppresses cancer cell migration and invasion by inhibiting MT1-MMP expression via AKT/GSK-3β/β-catenin pathway.
Wan G; Liu Y; Zhu J; Guo L; Li C; Yang Y; Gu X; Deng LL; Lu C
Cell Signal; 2019 Jul; 59():1-12. PubMed ID: 30844429
[TBL] [Abstract][Full Text] [Related]
6. Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma.
Arslan AD; Sassano A; Saleiro D; Lisowski P; Kosciuczuk EM; Fischietti M; Eckerdt F; Fish EN; Platanias LC
Oncogene; 2017 Oct; 36(43):6006-6019. PubMed ID: 28671669
[TBL] [Abstract][Full Text] [Related]
7. microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.
Wu D; Pan H; Zhou Y; Zhou J; Fan Y; Qu P
Mol Med Rep; 2014 Jun; 9(6):2491-8. PubMed ID: 24714873
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of motility and invasiveness of renal cell carcinoma induced by short interfering RNA transfection of beta 1,4GalNAc transferase.
Aoki H; Satoh M; Mitsuzuka K; Ito A; Saito S; Funato T; Endoh M; Takahashi T; Arai Y
FEBS Lett; 2004 Jun; 567(2-3):203-8. PubMed ID: 15178323
[TBL] [Abstract][Full Text] [Related]
9. Re: Human Schlafen 5 (SLFN5) is a Regulator of Motility and Invasiveness of Renal Cell Carcinoma Cells.
Atala A
J Urol; 2016 Apr; 195(4 Pt 1):1169. PubMed ID: 27302824
[No Abstract] [Full Text] [Related]
10. Effect of RNA interference of the expression of HMGA2 on the proliferation and invasion ability of ACHN renal cell carcinoma cells.
Liu Y; Fu QZ; Pu L; Song LL; Wang YY; Liu J; Wang ZL; Wang ZM
Mol Med Rep; 2017 Oct; 16(4):5107-5112. PubMed ID: 28849119
[TBL] [Abstract][Full Text] [Related]
11. Annexin A1 expression is correlated with malignant potential of renal cell carcinoma.
Yamanoi M; Yamanoi K; Fujii C; Fukuda MN; Nakayama J
Int J Urol; 2019 Feb; 26(2):284-290. PubMed ID: 30506742
[TBL] [Abstract][Full Text] [Related]
12. Tumor cell invasion of von Hippel Lindau renal cell carcinoma cells is mediated by membrane type-1 matrix metalloproteinase.
Petrella BL; Brinckerhoff CE
Mol Cancer; 2006 Dec; 5():66. PubMed ID: 17140440
[TBL] [Abstract][Full Text] [Related]
13. miR-33a inhibits cell growth in renal cancer by downregulation of MDM4 expression.
Jiang K; Sun F; Zhu J; Luo G; Ban Y; Zhang P
Mol Genet Genomic Med; 2019 Aug; 7(8):e833. PubMed ID: 31250570
[TBL] [Abstract][Full Text] [Related]
14. TRIM59 is a key regulator of growth and migration inrenal cell carcinoma.
Hu SH; Zhao MJ; Wang WX; Xu CW; Wang GD
Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):68-74. PubMed ID: 28719348
[TBL] [Abstract][Full Text] [Related]
15. Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability.
Tang J; Wang F; Cheng G; Si S; Sun X; Han J; Yu H; Zhang W; Lv Q; Wei JF; Yang H
J Exp Clin Cancer Res; 2018 Feb; 37(1):40. PubMed ID: 29482572
[TBL] [Abstract][Full Text] [Related]
16. The Expression of BTS-2 Enhances Cell Growth and Invasiveness in Renal Cell Carcinoma.
Pham QT; Oue N; Yamamoto Y; Shigematsu Y; Sekino Y; Sakamoto N; Sentani K; Uraoka N; Tiwari M; Yasui W
Anticancer Res; 2017 Jun; 37(6):2853-2860. PubMed ID: 28551621
[TBL] [Abstract][Full Text] [Related]
17. Renal carcinoma/kidney progenitor cell chimera organoid as a novel tumorigenesis gene discovery model.
Xu Q; Junttila S; Scherer A; Giri KR; Kivelä O; Skovorodkin I; Röning J; Quaggin SE; Marti HP; Shan J; Samoylenko A; Vainio SJ
Dis Model Mech; 2017 Dec; 10(12):1503-1515. PubMed ID: 29084770
[TBL] [Abstract][Full Text] [Related]
18.
Lin TC
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326089
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the gene expression profile in renal cell carcinoma after treatment with the histone deacetylase-inhibitor valproic acid and interferon-alpha.
Juengel E; Bhasin M; Libermann T; Barth S; Michaelis M; Cinatl J; Jones J; Hudak L; Jonas D; Blaheta RA
World J Urol; 2011 Dec; 29(6):779-86. PubMed ID: 20640575
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-182 suppresses clear cell renal cell carcinoma migration and invasion by targeting IGF1R.
Wang X; Li H; Cui L; Feng J; Fan Q
Neoplasma; 2016; 63(5):717-25. PubMed ID: 27468875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
